Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis

por Wang, Feng, He, Ming-Ming, Yao, Yi-Chen, Zhao, Xia, Wang, Zhi-Qiang, Jin, Ying, Luo, Hui-Yan, Li, Ji-Bin, Wang, Feng-Hua, Qiu, Miao-Zhen, Lv, Zhi-Da, Wang, De-Shen, Li, Yu-Hong, Zhang, Dong-Sheng, Xu, Rui-Hua
Publicado 2021

Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer

por Wang, Feng, He, Ming-Ming, Wang, Zi-Xian, Li, Su, Jin, Ying, Ren, Chao, Shi, Si-Mei, Bi, Bing-Tian, Chen, Shuang-Zhen, Lv, Zhi-Da, Hu, Jia-Jia, Wang, Zhi-Qiang, Wang, Feng-Hua, Wang, De-Shen, Li, Yu-Hong, Xu, Rui-Hua
Publicado 2019